These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 15106568)

  • 1. Heart attack gene discovered; prevention steps remain crucial.
    Heart Advis; 2004 Feb; 7(2):2. PubMed ID: 15106568
    [No Abstract]   [Full Text] [Related]  

  • 2. MEF2A sequence variants and coronary artery disease: a change of heart?
    Altshuler D; Hirschhorn JN
    J Clin Invest; 2005 Apr; 115(4):831-3. PubMed ID: 15841171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation of MEF2A in an inherited disorder with features of coronary artery disease.
    Wang L; Fan C; Topol SE; Topol EJ; Wang Q
    Science; 2003 Nov; 302(5650):1578-81. PubMed ID: 14645853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary artery disease and the MEF2A transcription factor.
    Olson EN
    Sci Aging Knowledge Environ; 2003 Dec; 2003(48):pe33. PubMed ID: 14657507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular genetics: are we there yet?
    Sturm AC
    J Med Genet; 2004 May; 41(5):321-3. PubMed ID: 15121766
    [No Abstract]   [Full Text] [Related]  

  • 6. Transcription factor MEF2A mutations in patients with coronary artery disease.
    Bhagavatula MR; Fan C; Shen GQ; Cassano J; Plow EF; Topol EJ; Wang Q
    Hum Mol Genet; 2004 Dec; 13(24):3181-8. PubMed ID: 15496429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic testing kit on the horizon for heart disease.
    Heart Advis; 2004 Dec; 7(12):2. PubMed ID: 15782432
    [No Abstract]   [Full Text] [Related]  

  • 8. Miscues on the "lack of MEF2A mutations" in coronary artery disease.
    Wang Q; Rao S; Topol EJ
    J Clin Invest; 2005 Jun; 115(6):1399-400; author reply 1400-1. PubMed ID: 15931371
    [No Abstract]   [Full Text] [Related]  

  • 9. Advances in the genetic basis of coronary artery disease.
    Wang Q
    Curr Atheroscler Rep; 2005 May; 7(3):235-41. PubMed ID: 15811259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-mef2 is a target for Tinman activation during Drosophila heart development.
    Gajewski K; Kim Y; Lee YM; Olson EN; Schulz RA
    EMBO J; 1997 Feb; 16(3):515-22. PubMed ID: 9034334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise increases MEF2- and GEF DNA-binding activity in human skeletal muscle.
    McGee SL; Sparling D; Olson AL; Hargreaves M
    FASEB J; 2006 Feb; 20(2):348-9. PubMed ID: 16368714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association and functional analyses of MEF2A as a susceptibility gene for premature myocardial infarction and coronary artery disease.
    Guella I; Rimoldi V; Asselta R; Ardissino D; Francolini M; Martinelli N; Girelli D; Peyvandi F; Tubaro M; Merlini PA; Mannucci PM; Duga S
    Circ Cardiovasc Genet; 2009 Apr; 2(2):165-72. PubMed ID: 20031581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins.
    Black BL; Olson EN
    Annu Rev Cell Dev Biol; 1998; 14():167-96. PubMed ID: 9891782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of Xenopus MyoD transcription by members of the MEF2 protein family.
    Wong MW; Pisegna M; Lu MF; Leibham D; Perry M
    Dev Biol; 1994 Dec; 166(2):683-95. PubMed ID: 7813786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant-interfering forms of MEF2 generated by caspase cleavage contribute to NMDA-induced neuronal apoptosis.
    Okamoto S; Li Z; Ju C; Scholzke MN; Mathews E; Cui J; Salvesen GS; Bossy-Wetzel E; Lipton SA
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3974-9. PubMed ID: 11904443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription of the myogenic regulatory gene Mef2 in cardiac, somatic, and visceral muscle cell lineages is regulated by a Tinman-dependent core enhancer.
    Cripps RM; Zhao B; Olson EN
    Dev Biol; 1999 Nov; 215(2):420-30. PubMed ID: 10545248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AVP induces myogenesis through the transcriptional activation of the myocyte enhancer factor 2.
    Scicchitano BM; Spath L; Musarò A; Molinaro M; Adamo S; Nervi C
    Mol Endocrinol; 2002 Jun; 16(6):1407-16. PubMed ID: 12040025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Centronuclear myopathy in mice lacking a novel muscle-specific protein kinase transcriptionally regulated by MEF2.
    Nakagawa O; Arnold M; Nakagawa M; Hamada H; Shelton JM; Kusano H; Harris TM; Childs G; Campbell KP; Richardson JA; Nishino I; Olson EN
    Genes Dev; 2005 Sep; 19(17):2066-77. PubMed ID: 16140986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drosophila mef2 expression during mesoderm development is controlled by a complex array of cis-acting regulatory modules.
    Nguyen HT; Xu X
    Dev Biol; 1998 Dec; 204(2):550-66. PubMed ID: 9882489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of the CAG repeat polymorphism of the MEF2A gene and coronary artery disease in a Chinese population.
    Han Y; Yang Y; Zhang X; Yan C; Xi S; Kang J
    Clin Chem Lab Med; 2007; 45(8):987-92. PubMed ID: 17579569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.